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While the long noncoding RNAs (ncRNAs) constitute
a large portion of themammalian transcriptome, their
biological functions has remained elusive. A few long
ncRNAs that have been studied in any detail silence
gene expression in processes such as X-inactivation
and imprinting. We used a GENCODE annotation of
the human genome to characterize over a thousand
long ncRNAs that are expressed in multiple cell lines.
Unexpectedly, we found an enhancer-like function
for a set of these long ncRNAs in human cell lines.
Depletion of a number of ncRNAs led to decreased
expression of their neighboring protein-coding
genes, including the master regulator of hematopoi-
esis, SCL (also called TAL1), Snai1 and Snai2. Using
heterologous transcription assays we demonstrated
a requirement for the ncRNAs in activation of gene
expression. These results reveal an unanticipated
role for a class of long ncRNAs in activation of critical
regulators of development and differentiation.INTRODUCTION
Recent technological advances have allowed the analysis of the
human and mouse transcriptomes with an unprecedented reso-
lution. These experiments indicate that a major portion of the
genome is being transcribed and that protein-coding sequences
only account for a minority of cellular transcriptional output (Ber-
tone et al., 2004; Birney et al., 2007; Cheng et al., 2005; Kapranov
et al., 2007). Discovery of RNA interference (RNAi) (Fire et al.,
1998) in C. elegans and the identification of a new class of small
RNAs known as microRNAs (Lee et al., 1993; Wightman et al.,
1993) led to a greater appreciation of RNA’s role in regulation
of gene expression. MicroRNAs are endogenously expressed
noncoding transcripts that silence gene expression by targeting
specific mRNAs on the basis of sequence recognition (Carthew
and Sontheimer, 2009). Over 1000 microRNA loci are estimated46 Cell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc.to be functional in humans, modulating roughly 30% of protein-
coding genes (Berezikov and Plasterk, 2005).
While microRNAs represent a minority of the noncoding tran-
scriptome, the tangle of long and short noncoding transcripts is
much more intricate, and is likely to contain as yet unidentified
classes of molecules forming transcriptional regulatory networks
(Efroni et al., 2008; Kapranov et al., 2007). Long ncRNAs are tran-
scripts longer than 100 nts which in most cases mirror the
features of protein-coding genes without containing a functional
open reading frame (ORF). Long ncRNAs have been implicated
as principal players in imprinting and X-inactivation. The
imprinting phenomenon dictates the repression of a particular
allele, depending on its paternal or maternal origin. Many clus-
ters of imprinted genes contain ncRNAs, and some of them
have been implicated in the transcriptional silencing (Yang and
Kuroda, 2007). Similarly, the X chromosome inactivation relies
on the expression of a long ncRNA named Xist, which is thought
to recruit, in a cis-specific manner, protein complexes establish-
ing repressive epigenetic marks that encompass the chromo-
some (Heard and Disteche, 2006). There is also a report indi-
cating that a long ncRNA expressed from the HOXC locus may
affect the expression of genes in theHOXD locuswhich is located
onadifferent chromosome (Rinn et al., 2007).More recently, a set
of long ncRNAs has been identified in mouse, through the anal-
ysis of the chromatin signatures (Guttman et al., 2009). There
has also been reports of divergent transcription of short RNAs
flanking transcriptional start sites of the active promoters (Core
et al., 2008; Preker et al., 2008; Seila et al., 2008).
In search of a function for long ncRNAs, we used the
GENCODE annotation (Harrow et al., 2006) of the human
genome. To simplify our search we subtracted transcripts over-
lapping the protein-coding genes. Moreover, we filtered out the
transcripts that may correspond to promoters of protein-coding
genes and the transcripts that belong to known classes of
ncRNAs. We identified 3019 putative long ncRNAs that display
differential patterns of expression. Functional knockdown of
multiple ncRNAs revealed their positive influence on the neigh-
boring protein-coding genes. Furthermore, detailed functional
analysis of a long ncRNA adjacent to the Snai1 locus using
reporter assays demonstrated a role for this ncRNA in an RNA-
dependent potentiation of gene expression. Our studies suggest
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Figure 1. Identification of Novel Long
ncRNAs in Human Annotated by GENCODE
(A) Analysis of coding potential using Gene ID for
ancestral repeats (AR), long ncRNAs annotated
by GENCODE and protein-coding genes.
(B) Conservation of the genomic transcript
sequences for AR, long ncRNAs, protein-coding
genes, and (C) of their promoters.
(D) Expression analysis of 3,019 long ncRNA in
human fibroblasts, HeLa cells and primary human
keratinocytes, showing numbers for transcripts
detected in each cell line and the overlaps
between cell lines. All microarray experiments
have been done in four replicates. See also
Figure S1 and Table S1 and Table S2.a role for a class of long ncRNAs in positive regulation of protein-
coding genes.
RESULTS
Noncoding RNAsAre Expressed andRespond to Cellular
Differentiating Signals
To assign a function to uncharacterized human long ncRNAs, we
identified unique long noncoding transcripts using the annota-
tion of the human genome provided by the GENCODE (Harrow
et al., 2006) and performed by human and vertebrate analysis
and annotation (HAVANA) group at Sanger Institute. Such
genomic annotation is being produced in the framework of the
ENCODE project (Birney et al., 2007). At the time of our analysis,
the GENCODE annotation encompassed about one third of the
human genome. Such an annotation relies on the human expert
curation of all available experimental data on transcriptional
evidence, such as cloned cDNA sequences, spliced RNAs and
ESTs mapped on to the human genome.
We focused on ncRNAs that do not overlap the protein-coding
genes in order to simplify the interpretation of our functional anal-
ysis of ncRNAs. This included the subtraction of all transcripts
mapping to exons, introns and the antisense transcripts overlap-
ping the protein-coding genes. We also excluded transcripts
within 1 kb of the first and the last exons as to avoid promoter
and 30-associated transcripts (Fejes-Toth et al., 2009; Kapranov
et al., 2007), that display a complicated pattern of short tran-
scripts (Core et al., 2008; Preker et al., 2008; Seila et al., 2008).
Furthermore, we excluded all known noncoding transcripts
from our list of putative long ncRNAs. This analysis resulted in
3019 ncRNAs, which are annotated by HAVANA to have noCell 143, 46–5coding potential, expressed from 2286
unique loci (some loci display multiple
alternative spliced transcripts) of the
human genome (Experimental Proce-
dures, Table S1 available online). The
average size of the noncoding transcripts
is about 800 nts with a range from 100 nts
to 9100 nts. Interestingly, the long
ncRNAs display a simpler transcription
unit than that of protein-coding genes
(Figure S1A). Nearly 50% of our longncRNAs contain a single intron in their primary transcript (Fig-
ure S1A). Moreover, analysis of their chromatin signatures indi-
cated similarities with protein-coding genes. Transcriptionally
active ncRNAs display histone H3K4 trimethylation at their
50-end (Figure S1B) and histone H3K36 trimethylation in the
body of the gene (Figure S1C).
Analysis of protein coding potential of the ncRNAs using
GeneID (Blanco et al., 2007; Parra et al., 2000) shows ncRNAs
coding potential comparable to that of ancestral repeats (Lunter
et al., 2006), supporting the HAVANA annotation of these tran-
scripts as noncoding (Figure 1A). Moreover, comparison of
ncRNAswith protein-coding genes andcontrol sequences corre-
sponding to ancestral repeats (Lunter et al., 2006) reveals that
ncRNA sequence conservation is lower than that of protein-
codinggenes,buthigher than thatofancestral repeats (Figure1B).
A similar case is seenwith thepromoter regions (Figure1C). These
results are in concordance with previous observations in the
mouse genome (Guttman et al., 2009; Ponting et al., 2009).
Next we used custom-made microarrays (Experimental
Procedures) which were designed to include an average of six
probes (nonrepetitive sequences) against each ncRNA transcript
to detect their expression. We analyzed the expression pattern
of ncRNAs using three different human cell lines (Figure 1D).
Overall, we detected 1167 ncRNAs expressed in at least one
of the three cell types and 576 transcripts common among the
three cell types (Figure 1D). We validated the expression of 16
ncRNAs that mapped to the 1% of the human genome investi-
gated by the original ENCODE study (Birney et al., 2007) using
quantitative polymerase chain reaction (qPCR) in three different
cell lines (Table S2). Furthermore, we could find evidence for
expression of 80% of our noncoding transcripts in at least one8, October 1, 2010 ª2010 Elsevier Inc. 47
human tissue in a recent high throughput sequencing of the
human transcriptome (Wang et al., 2008).
To assess whether ncRNAs respond to cellular differentiating
signals, we induced the differentiation of human primary kerati-
nocytes using 12-O-tetradecanoylphobol 13-acetate (TPA). We
monitored the expression of ncRNAs using custom microarrays.
Expression of protein-coding genes was monitored using
conventional Agilent arrays containing nearly all human mRNAs.
We prepared RNA from human primary keratinocytes before
and following treatment with TPA. As shown in Figure 2A and
Table S3, we could detect 687 ncRNAs in keratinocytes, where
104 (or 15.1%) respond to TPA treatment by over 1.5-fold. Simi-
larly, 21.3% of protein coding-genes display a change in expres-
sion of over 1.5-fold (Figure 2B). While around half of the
TPA-regulated protein-coding genes increase and a similar
proportion decrease their expression following differentiation,
70% of the TPA-regulated ncRNAs increase their expression
whereas only 30%showa decrease (Figures 2A and 2B). Further-
more, analysis of the protein-coding genes in the 500 kb window
surrounding the TPA-regulated ncRNAs indicates a significant
enrichment in genes involved in differentiation and morphogen-
esis (Figure 2C). An example of such change in expression of an
important gene involved in extra-cellular matrix is shown in
Figure 2D. Extracellular Matrix Protein 1 (ECM1) gene and an
ncRNAadjacent to it displayeda 5 and1.7 fold induction following
TPA treatment, respectively. (Figure 2D, upper panel). qPCRanal-
ysis shows the TPA-mediated induction of ECM1 and the ncRNA
as 14 and 4 fold, respectively (Figure 2D, bottom panel). Taken
together, we found that many of the GENCODE annotated tran-
scripts are expressed in multiple cell lines and that they display
gene expression responsiveness to differentiation signals.
Noncoding RNAs Display a Transcriptional
Activator Function
To assess the function of our set of long ncRNAs, we reasoned
that similar to long ncRNAs function at the imprinting loci, our
collection of ncRNAs may act to regulate their neighboring
genes. To test this hypothesis, we used RNA interference to
deplete a set of ncRNAs. We initially chose ncRNAs that showed
a differential expression following keratinocyte differentiation.
However, to obtain a reproducible knockdown we had to use
cell lines that are permissive to transfection by siRNAs. We
used five different cell lines for our analyses in which the candi-
date ncRNAs display a detectable expression (Figure 3).
We validated the expression of our experimental set of
ncRNAs and the absence of protein-coding potential using rapid
amplification of 50 and 30 complementary DNA ends (50 and 30
RACE), PCR and in vitro translation (Figure S3). These experi-
ments confirmed the expression of ncRNAs and showed that
they do not yield a product in an in vitro translation assay (Figures
S3A and S3B), supporting the noncoding annotation of our set of
ncRNAs. In two cases, the ncRNAs adjacent to Snai2 and TAL1
loci, we found evidence of a longer ncRNA transcript than that
annotated by HAVANA (Figure S3).
We began by examining small interfering RNAs (siRNAs)
against the ncRNA next to ECM1 in order to assess its functional
role following its depletion (for reasons that will follow, this class
of RNA is designated as noncoding RNA-activating1 through 7,48 Cell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc.ncRNA-a1-7). HEK293 cells were used for these experiments
because of the ease of functional knockdown and the detectable
amounts of ncRNA-a1 and ECM1 in this cell line. We compared
the results obtained using two siRNAs against ncRNA-a1 to data
obtained following the transfection of two control siRNAs (for the
visual simplicity only one siRNA is shown (Figure 3A), the values
for both siRNAs can be seen in Table S4). The two siRNAs
produced comparable results. We interrogated a 300 kb window
around the ncRNA-a1 containing six protein-coding genes using
qPCR.
Surprisingly, unlike the silencing action of long ncRNAs in
imprinting and X-inactivation, depletion of ncRNA-a1 adjacent
to ECM1 resulted in a concomitant decrease in expression of
the neighboring ECM1 gene (Figure 3A). This effect was specific,
as we did not detect any change in the other protein-coding
genes surrounding ncRNA-a1 (Figure 3A). To ascertain that
ncRNA-a1 is not a component of the ECM1 30 untranslated
region, we used primer pairs spanning the ECM1 and ncRNA-a1
genes. We were not able to detect a transcript comprised of the
two genes in HEK293 cells, supporting the contention that the
two transcripts are independent transcriptional units (Fig-
ure S2A). Furthermore, published ChIP experiments (Euskirchen
et al., 2007) show the presence of RNA polymerase II and tri-
methyl H3K4 peaks at the transcription start site of ncRNA-a1
in several cell lines, further attesting to an independent transcrip-
tional start site for ncRNA-a1. Moreover, knocking down the
ECM1 gene did not affect the expression level of ncRNA-a1 or
any of the other protein-coding genes analyzed in the locus,
further supporting the independence of ECM1 transcript from
that of ncRNA-a1 (Figure S2B).
Next we analyzed ncRNA-a2 flanking the histone demethylase
JARID1B/KDAM 5B which also shows increased expression
following keratinocyte differentiation. These experiments were
performed in HeLa cells as they showed detectable expression
of ncRNA-a2. Interestingly, while depletion of ncRNA-a2 did
not change JARID1B/KDAM 5B levels, the KLHL12, a gene
known for its negative regulation of the Wnt-beta catenin
pathway, on the opposite strand displayed a significant reduc-
tion (Figure 3B). Although the decrease in KLHL12 was small
(about 20%), no other protein-coding gene in the locus displayed
a difference in expression (Figure 3B).
To extend our findings and to determine whether regulation of
neighboring protein-coding genes is a common function of
ncRNAs, we interrogated the ncRNA-a3 flanking the stem cell
leukemia gene (SCL, also called TAL1). TAL1 is a basic helix-
loop-helix protein which serves as the master regulator of hema-
topoiesis (Lecuyer and Hoang, 2004). This locus contains two
ncRNAs on different strands of DNA. We used MCF-7 cells to
assess the depletion of ncRNA-a3, since the expression of
ncRNA-a3 and TAL1 could be readily detected in these cells.
However, neither PDZK1IP1 nor ncRNA-a4 could be detected
by qPCR in MCF-7 cells. Depletion of ncRNA-a3 resulted in
a specific and potent reduction of TAL1 expression (Figure 3C).
While depletion of ncRNA-a3 did not affect either STIL or CMPK1
genes, a significant reduction in CYP4A11 gene on the opposite
strand of the DNA was detected (Figure 3C).
We next turned our attention to ncRNA-a4 which was not ex-
pressed at a detectable level in MCF7 cells. We could reliably
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Figure 2. Long ncRNAs Display Responsiveness to Differentiation Signals in Human Primary Keratinocytes
(A and B) Distribution of differentially expressed transcripts (dark colors) following TPA treatment for long ncRNAs (A), and mRNAs (B). Lighter colors show total
number of transcripts, darker colors and percentage show number of differentially expressed transcripts. Bar-plots show number and fractions of transcripts
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(C) Gene onthology analysis of genes flanking the differentially expressed long ncRNAs (red) compared to genes flanking random positions (black).
(D) Graphic representation of a locus with induction of the long ncRNA ncRNA-a1 and the adjacent ECM1 gene, with expression values from microarrays (upper
panel) and qPCR quantification of transcripts (lower panel). Microarray experiments and qPCR validation are done in four replicates. Data shown are mean ± SD.
See also Figure S2 and Table S3.detect ncRNA-a4 in Jurkat cells. While we could not efficiently
knockdown ncRNA-a3 in Jurkat cells, siRNAs specific to
ncRNA-a4 reproducibly reduced its levels by about 50%(Figure 3D). Importantly, reduced levels of ncRNA-a4 resulted
in a consistent and significant decrease in the level of the gene
CMPK1 which is over 150 kb downstream of ncRNA-a4Cell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc. 49
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Figure 3. Stimulation of Gene Expression by Activating RNAs
The thick black line representing each gene shows the span of the genomic region including exons and introns. The targeted activating RNAs are shown in red.
Bar-plots show RNA levels as determined by qPCR.
(A) ncRNA-a1 locus in HEK293 cells.
(B) ncRNA-a2 locus in HeLa cells.
(C) ncRNA-a3 locus in MCF-7 cells.
(D) ncRNA-a4 locus in Jurkat cells.
(E) ncRNA-a5 locus in HeLa cells.
(F) ncRNA-a6 locus in A549 cells. All values are relative to GAPDH expression and relative to control siRNA transfected cells set to an average value of 1. The scale
bar represents 100 kb and applies to all figure panels. Error bars showmean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
by two-tailed Student’s t test. See also Figure S3 and Table S4. The results represent at least six independent experiments. See also Figure S3 and Table S4.(Figure 3D). We do not detect any changes in the other protein-
coding genes surrounding ncRNA-a4. Next we depleted
ncRNA-a5 which is adjacent to the E2F6 gene, an important
component of a polycomb-like complex (Ogawa et al., 2002).
Knockdown of ncRNA-a5 did not affect the E2F6 gene.
However, depletion of ncRNA-a5 resulted in a specific reduction
in ROCK2 expression levels in HeLa cells, which is located
upstream of ncRNA-a5 (Figure 3E).
Finally, we examined the Snai1 and Snai2 loci in A549 cells
(Figure 3F and Figure 4). The Snail family of transcription factors
are implicated in the differentiation of epithelia cells into mesen-
chymal cells (epithelial-mesenchymal transition) during embry-50 Cell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc.onic development (Barrallo-Gimeno and Nieto, 2005; Savagner,
2001). Snai2 shows a significant reduction in expression when
the adjacent ncRNA-a6 is depleted, an effect that is not seen
on EFCAB1, the only other protein-coding gene within 300 kb
of the ncRNA-a6 (Figure 3F). In total, we have examined 12 loci
where we were able to efficiently knockdown the ncRNAs using
siRNAs (Table S5). We were able to show that in 7 cases, the
ncRNA acts to potentiate the expression of a protein-coding
gene within 300 kb of the ncRNA. It is possible that the remaining
ncRNAs which did not display a positive effect on the neigh-
boring genes within the 300 kb window, exert their action over
longer distances which was not assessed in our analysis. Taken
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Figure 4. Knockdown of ncRNA-a7 Specifi-
cally Targets Snai1 Expression
(A) As in Figure 3, the ncRNA-a7 locus is depicted
showing effects on RNA levels for the surrounding
genes with and without knockdown of ncRNA-a7.
The results represent mean ± SEM of at least six
independent experiments. **p < 0.01 by one-tailed
Student’s t test.
(B) Migration assay of A549 cells with control (right
panel) or ncRNA-a7 (left panel) siRNA transfec-
tions.
(C) Quantification of the data shown in (B).
Experiments in (B) and (C) are done in three repli-
cates and are shown as mean ± SEM. ***p <
0.001 by two-tailed Student’s t test. See also
Figure S4 and Table S5.together, our results indicate that a subset of ncRNAs has acti-
vating functions and therefore we have named them ncRNA-
activator (ncRNA-a) followed by a number to distinguish each
activating long ncRNA.
ncRNA-a7 Is a Regulator of Snai1
As mentioned above, Snai1 is a member of the Snail zinc-finger
family, which comprises transcription factors with diverse func-
tions in development and disease (Barrallo-Gimeno and Nieto,
2005; Nieto, 2002). The Snail gene family is conserved among
species from Drosophila to human and has been shown to func-
tion as mesodermal determinant genes (Barrallo-Gimeno and
Nieto, 2005; Nieto, 2002). Snail genes are the regulators of cell
adhesion, migration and epithelial-mesenchymal transition
(EMT) (Barrallo-Gimeno and Nieto, 2005; Nieto, 2002). Analysis
of the ncRNA close to the Snai1 gene provided us with an oppor-
tunity to combine our gene expression analysis with analysis of
changes in cellular migration. Knockdown of ncRNA-a7 resultedCell 143, 46–5in a specific reduction in Snai1 levels (Fig-
ure 4A). The expression of the four other
protein-coding genes in this locus does
not change following the depletion of
ncRNA-a7. Concomitantly, knockdown
of ncRNA-a7 has a significant phenotypic
effect in cell migration assays, reducing
the number of migrating cells to about
10% of that of the control (Figures 4B
and 4C), consistent with the phenotypic
changes following the depletion of Snai1
(Figures 4B and 4C).
Since the knockdown of ncRNA-a7 or
Snai1 had similar consequences on
cellular migration, we assessed their
depletion on gene expression in A549
cells using Agilent arrays. We could not
detect the basal level of Snai1 on the
array, while Snai1 was readily detectable
using quantitative PCR. Interestingly,
depletion of Snai1 or ncRNA-a7 resulted
in similar changes in gene expression
profiles (Figure 5A and Table S6). Not
only did we observe a similar trend ingenes that were affected upon the knockdown of either gene
but also a significant number of genes that were upregulated
were in common in both treatments (Figures 5A and 5B). Since
Snai1 is a known transcriptional repressor, depletion of Snai1
or ncRNA-a7 should result in an upregulation of Snai1 target
genes. Indeed, a number of genes that were commonly upregu-
lated were direct targets of Snai1 (Figure 5C, upper panel) (De
Craene et al., 2005). Depletion of either ncRNA-a7 or Snai1
also resulted in downregulation of a set of genes with a partial
overlap between the genes downregulated following the two
treatments (Figure 5B). Interestingly, Aurora-kinase A a gene
that is 6MB down-stream of ncRNA-a7 was specifically downre-
gulated following the depletion of ncRNA-a7, suggesting a long
range effect for ncRNA-a7 (Figure 5C). Taken together, these
results indicate that while the depletion of ncRNA-a7 partially
mimic the gene expression profile observed following Snai1
depletion, there are a number of gene expression changes
resulting from the ncRNA-a7 depletion that occur independently8, October 1, 2010 ª2010 Elsevier Inc. 51
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Figure 5. Microarray Analysis of Snai1 and
ncRNA-a7 Knockdown
Snai1 or ncRNA-a7 were knocked down using
siRNA in A549 cells and the isolated RNA analyzed
on microarrays in duplicate experiments.
(A) All genes differentially expressed (>1.5-fold or
<0.6-fold compared to control) in either Snai1 or
ncRNA-a7 knockdown, or both, are shown clus-
tered in a heat map according to expression
profile. Numbers are log(2) transformed and color
scale is shown below the heat map.
(B) Analysis of genes showing upregulation (>1.5
fold) or downregulation (<0.6 fold) in both Snai1
and ncRNA-a7 knockdown. Numbers represent
number of genes regulated in the indicated
condition.
(C and D) (C) Validation of microarray data by
qPCR and (D) analysis of the Snai1 locus
and targets of Snai1 upon overexpression of
ncRNA-a7. ncRNA-a7 was overexpressed from
a vector in A549 cells and expression of select
genes were measured by qPCR. Y-axes show
expression value relative to GAPDH of the indi-
cated gene. Values are normalized to those of
control siRNA transfected cells, set to 1. **p < 0.01,
***p < 0.001 by one-tailed Student’s t test. See also
Table S6.of changes in Snai1. Therefore, it is likely that depletion of
ncRNA-a7 may have other effects on gene expression which
may be mediated through other targets in trans.
To specifically address whether ncRNA-a7 may exert its
effects in trans, we assessed the gene expression changes in
Snai1 locus as well as some of the targets that were changed
by depletion of ncRNA-a7 or Snai1 following the overexpression
of ncRNA-a7 (Figure 5D). Overall, we did not observe changes in
gene expression for any of the ncRNA-a7 targets following its
overexpression (Figure 5D, ncRNA-a7 was overexpressed 150
fold). While these results suggest that ncRNA-a7 exerts its local
gene expression changes in cis, it is likely that other targets may
be influenced in trans. Taken together, these experiments reveal
a role for ncRNA-a in positive regulation of expression of neigh-
boring protein-coding genes and show that this effect is not
specific to any one locus and may represent a general function
for ncRNAs in mammalian cells.
ncRNA Activation of Gene Expression of a Heterologous
Reporter
Previous studies have shown that distal activating sequences/
enhancers can stimulate transcription when placed adjacent
to a heterologous promoter, a methodology widely used to vali-
date potential enhancers (Banerji et al., 1983, 1981; Gillies
et al., 1983; Heintzman et al., 2009; Kong et al., 1997). To func-52 Cell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc.tionally dissect the influence of the
ncRNA activation on the expression of
an adjacent gene, we constructed
vectors with inserts containing either
ncRNA-a3 and -a4 from a bidirectionalpromoter, ncRNA-a5 or ncRNA-a7, and placed them down-
stream of Firefly luciferase driven by a thymidine kinase (TK)
promoter in a reporter vector (pGL3-TK-ncRNA-a), (Figure 6A).
We included 1–1.5 kb upstream of the ncRNA-as to contain
their endogenous promoters and 500 bps downstream in the
reporter vector. We also produced a control vector (pGL3-
TK-control) in which 4 kb of DNA without transcriptional poten-
tial was cloned down-stream of Firefly luciferase similar to the
ncRNA activation reporters (Figure 6B). A vector containing Re-
nilla luciferase was used to control for transfection efficiency.
Importantly, inclusion of either of the three ncRNA-a inserts
result in an enhancement of transcription ranging from 2- to
7-fold (Figures 6C–6E). This effect is specific as pGL3-TK-
control vector do not enhance the basal TK promoter activity
(Figures 6C–6E). To demonstrate that the observed potentiation
of gene expression is mediated through the action of ncRNA-a,
we knocked down the ncRNA-a in question for each reporter
construct using specific siRNAs (Figures 6C–6E). Interestingly
while depletion of ncRNA-a7 and ncRNA-a5 completely abol-
ished the increased transcription, depletion of ncRNA-a3
and/or ncRNA-a4 resulted in a partial decrease in transcrip-
tional enhancement (Figures 6C–6E). These results suggest
that while ncRNA-a play a major role in transcriptional activa-
tion, other DNA elements in the cloned ncRNAa-3/4 region
may also contribute to increased transcription.
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Figure 6. ncRNA-Activators Potentiate Transcription of a Reporter Gene
(A) ncRNA-a 3/4, 5 and 7 were cloned and inserted downstream of luciferase driven by a TK-promoter in a reporter plasmid as shown.
(B) Graphical representation of the inserts in the various vectors used. The pGL3-TK-Control vector contains an insert of approximately 4 kb containing no anno-
tated evidence of transcription. The depicted inserts show exons and transcriptional direction of the ncRNA-a.
(C–E) Luciferase reporter assays. The Firefly luciferase vectors were cotransfectedwith a Renilla luciferase vector (pRL-TK) for transfection control. (C) The vector
containing ncRNA-a3 and ncRNA-a4 from a bidirectional promoter, with control siRNA or siRNAs toward either of the two ncRNA-a, or both. (D) Reporter with
ncRNA-5, and (E) the reporter with the ncRNA-a7 inserted downstream of luciferase. X axes show relative Firefly (FL) to Renilla (RL) luciferase activity. Cotrans-
fected siRNAs are indicated to the right of the bars. All data shown are mean ± SE from six independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 by one-
tailed Student’s t test.Dissection of the ncRNA-a7 in a Reporter Construct
An important property of enhancing sequences is their orienta-
tion independence (Imperiale and Nevins, 1984; Khoury and
Gruss, 1983; Kong et al., 1997).We designed reporter constructs(Figure 7A) in which the ncRNA-a7 sequence is reversed (pGL3-
TK-ncRNA-a7-RV) in order to assess its orientation indepen-
dence. The ncRNA-a7-RV construct displayed a similar tran-
scriptional enhancing activity as the construct containing theCell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc. 53
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Figure 7. RNA-Dependent Activation of a Reporter
Gene by ncNRA-a7
(A) Properties of the ncRNA-a7 containing luciferase
reporter vector. (B, C, E, and F) Luciferase reporter assays.
The Firefly luciferase vectors were cotransfected with
a Renilla luciferase vector (pRL-TK) for transfection
control. (D) Semiquantitative PCR of ncRNA-a7. (B)
Reporter experiments with the ncRNA-a7 insert reversed
as indicated in the left panel. (C) The TK-promoter driving
luciferase expression was deleted from the construct and
expression values are shown relative to the pGL3-TK
control plasmid as a reference. (E) Truncated reporter
constructs containing the ncRNA-a7 promoter and down-
stream sequences, but not the ncRNA-a7 sequence
[pGL3-TK-delta(ncRNA-a7)], or one with a poly(A) signal
in the beginning of the ncRNA-a7 to induce premature pol-
yadenylation [pGL3-TK-ncRNA-a7-p(A)]. See also (D) for
analysis of expression from these plasmids. (F) Protein
coding sequences were inserted in place of ncRNA-a7
downstream of the ncRNA-a7 promoter. Full-length
GTSF1L or ID1 sequences are used. X axes show relative
Firefly (FL) to Renilla (RL) luciferase activity. All data shown
are mean ± SE from six independent experiments. ***p <
0.001 by one-tailed Student’s t test.
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ncRNA-a7 insert in its endogenous orientation with respect to
the regulated gene (Figure 7B).
To show that luciferase expression requires a promoter and
that ncRNA-7a cannot act as a proximal promoter, we deleted
the TK promoter from the reporter vectors. As shown in
Figure 7C, ncRNA-a7 cannot drive transcription of the Firefly
luciferase in the absence of a proximal TK promoter. These
experiments demonstrate that sequences corresponding to
ncRNA-a7 transcription unit can function to activate expression
of a heterologous promoter in an orientation-independent
manner, but cannot act as a promoter itself.
To further verify that ncRNA-a7 is the active component of the
transcriptional enhancement, we constructed two reporters in
which ncRNA-a7 sequences are either deleted or shortened by
placing a strong polyadenylation signal within the ncRNA-
a genomic sequence but close to the transcriptional start site,
to induce premature polyadenylation (Figures 7D and 7E). Both
modifications result in loss of the increased gene expression
(Figure 7E) compared to constructs where ncRNA-a7 is ex-
pressed. Finally, to assess whether the RNA corresponding to
ncRNA-7a is critical for increased gene expression, we devel-
oped constructs where DNA sequences corresponding to two
different protein-coding genes were positioned in the place of
ncRNA-a7 (Figure 7F), keeping the endogenous ncRNA-a7
promoter. Neither of these constructs displayed an increased
gene expression compared to that of the control constructs
(Figure 7F). Taken together, these experiments demonstrate
that the potentiation of gene expression is signaled by the
ncRNA-a and is not merely the result of the transcription of the
ncRNA.
DISCUSSION
We used the annotation of the human genome performed by
GENCODE to arrive at a collection of long ncRNAs that are ex-
pressed from loci independent of those of protein-coding genes
or previously described nc RNAs. GENCODE annotation encom-
passes both protein-coding and noncoding transcripts and relies
on experimental data obtained through the analysis of cDNAs,
ESTs and spliced RNAs. Our collection of 3,000 transcripts
correspond to the manual curation of about a 1/3 of the human
genome. Analysis of the GENCODE data indicates that nearly
all of their noncoding annotated transcripts are spliced
(Figure S1A).
Importantly, the median distance of an ncRNA transcript to
a protein-coding gene is over a 100 kb making it an unlikely
scenario for the ncRNA to be an extension of protein-coding
transcripts (Figures S2C and S2D). Moreover, transcriptionally
active ncRNAs display similar chromatin modifications seen
with expressed protein-coding genes (Figures S1B and S1C).
Furthermore, the analyzed ncRNAs display RNA pol(II), p300
and CBP occupancy at levels similar to those of the surrounding
protein coding genes, consistent with their transcriptional inde-
pendence (Figure S4). Although our analysis is focused on
understanding the function of a set of ncRNAs annotated by
GENCODE, the human transcriptome includes other forms of
ncRNAs with important regulatory functions that have not been
included in our study. These include the antisense transcriptsarising from protein-coding genes, precursors of microRNAs
as well as a wealth of unspliced transcripts described in multiple
studies (Guttman et al., 2009; Kapranov et al., 2007; Rinn et al.,
2007).
Taken together, the novelty of our work lies in the following.
First, we show that at multiple loci of the human genome deple-
tion of a long ncRNA leads to a specific decrease in the expres-
sion of neighboring protein-coding genes. Previous studies
analyzing the function of long ncRNAs in X-inactivation or the
imprinting phenomenon point to their role in silencing of gene
expression (Mattick, 2009). Second, we show that the enhance-
ment of gene expression by ncRNAs is not cell specific as we
observe the effect in five different cell lines. Third, this enhance-
ment of gene expression is mediated through RNA, as depletion
of such activating ncRNAs abrogate increased transcription of
the neighboring genes. Fourth, through the use of heterologous
reporter assays, we suggest that activating ncRNAs mediate
this RNA-dependent transcriptional responsiveness in cis. Fifth,
we show that similar to classically defined distal activating
sequences, ncRNA-mediated activation of gene expression is
orientation independent. Sixth, we present evidence that similar
to defined activating sequences, ncRNAs cannot drive transcrip-
tion in the absence of a proximal promoter. Finally, we demon-
strate that the activation of gene expression in the heterologous
reporter system is mediated through RNA as multiple
approaches depleting the RNA levels lead to abrogation of the
stimulatory response. Therefore, we have uncovered a new bio-
logical function in positive regulation of gene expression for
a class of ncRNAs in human cells.
There are previous reports of individual ncRNAs having a posi-
tive effect on gene expression. The 3.8 kb Evf-2 ncRNA was
shown to form a complex with the homeodomain-containing
protein Dlx2 and lead to transcriptional enhancement (Feng
et al., 2006). Similarly, the ncRNA HSR1 (heat-shock RNA-1)
forms a complex with HSF1 (heat-shock transcription factor 1),
resulting in induction of heat-shock proteins during the cellular
heat-shock response (Shamovsky et al., 2006) and an isoform
of ncRNASRA (steroid receptorRNAactivator) functions to coac-
tivate steroid receptor responsiveness (Lanz et al., 1999). Our
findings that activating ncRNAs positively regulate gene expres-
sionextend theseprevious studiesanddemonstrate that theacti-
vation of gene expression by long ncRNAmay be a general func-
tion of a class of long ncRNAs.Moreover, whether ncRNA effects
seen in our study are mediated through association with specific
transcriptional activators is not known. However, this is a likely
scenario given previous examples of an RNA-mediated respon-
siveness. Other possibilities include a formation of an RNA-DNA
hybridat the locusof thencRNAor theprotein-coding genewhich
may result in enhanced binding of the sequence specific DNA
binding proteins or chromatin modifying complexes.
A recent study uncovers a set of bidirectional transcripts
(termed eRNA) that are derived from sites in the human genome
that show occupancy by CBP, RNA polymerase II and are deco-
rated by monomethyl Histone H3 lysine 4 (H3K4) (Kim et al.,
2010). Moreover, they show that the expression of such tran-
scripts is correlated with their nearest protein-coding genes.
There are fundamental differences between their collection of
2000 transcripts and our GENCODE set of transcripts. First,Cell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc. 55
while all their eRNAs are bidirectional, only about 1% of our
ncRNAs show evidence of bidirectionality (see the example
shown in the TAL1 locus). Second, our analysis of the histone
modifications of a subset of ncRNAs that are expressed in lymph
(Barski et al., 2007) indicates the presence of H3K4 trimethyla-
tion at the transcriptional start sites and H3K36 trimethylation
at the body of the gene (Figures S1B and S1C). This is in stark
contrast to eRNA loci where there is an absence of H3K4 tri-
methyl marks and the predominant chromatin signature is the
monomethyl H3K4. Third, eRNAs are reported to be predomi-
nantly not polyadenylated. The majority of our collection of
ncRNAs show evidence of polyadenylation as they were ampli-
fied using oligo-dT-primed reactions and furthermore 41%
display the presence of a canonical polyadenylation site. Anal-
ysis of the protein-coding transcripts revealed that a similar
proportion (52%) to that of our ncRNAs contain the canonical
polyadenylation sites. Finally, while we show that a set of our
ncRNAs function to enhance gene expression, there is no
evidenceprovided for eRNAsexertingabiological function.While
webelieve that eRNAsdesignate adifferent class of ncRNAs than
ncRNA-a described in our study, it is temping to speculate that
many of the ncRNA-a and their promoters may correspond to
mammalian enhancers or polycomb/trithorax response elements
(PRE/TREs). In such a scenario, binding of polycomb or trithorax
proteins to proximal promoters of ncRNA-a will regulate the
expression of ncRNA-a which in turn impact the expression of
the protein-coding gene at the distance.
Another set of recently published ncRNAs were termed long
intervening noncoding RNA or lincRNAs (Guttman et al., 2009).
The comparison of our ncRNAs and the lincRNAs show that
about 13% of the ncRNAs defined by ENCODE overlap the
broad regions encoding a set of recently identified human
lincRNAs (Khalil et al., 2009). The overlap between our ncRNAs
and lincRNAs are even smaller (4%) if one considers only the
exons corresponding to lincRNAs. Importantly, the studies with
lincRNAs did not reveal any transcriptional effects in neighboring
genes (Khalil et al., 2009). Therefore, it is likely that lincRNAs
describe a distinct set of ncRNAs compared to those annotated
by GENCODE. Similar to the diverse functions for proteins,
ncRNAs such as lincRNAs may play other roles in regulating
gene expression.
The GENCODE annotation used in this study encompasses
only a third of the human genome. Therefore, the number of
ncRNAs in human cells is likely to grow and may equal or even
surpass the number of protein-coding genes. Our considerations
for selection of ncRNAs excluded all ncRNAs associated with
protein-coding genes and their promoters, as well as known
ncRNAs. Therefore, the repertoire of the noncoding transcripts
in human cells contains many more transcripts than those cata-
loged in this study. Specifically, there have been reports of
pervasive amount of antisense transcription as well as transcrip-
tion mapping to promoter regions of protein-coding genes (Core
et al., 2008; Denoeud et al., 2007; Kapranov et al., 2007; Preker
et al., 2008; Seila et al., 2008). Whether such transcripts will have
biological functions similar to those described for activating
ncRNAs in our study is not known. However, it is clear that future
genome-wide genetic analysis of ncRNAs in mammalian cells
will begin to shed light on different classes of the ncRNAs.56 Cell 143, 46–58, October 1, 2010 ª2010 Elsevier Inc.The precise mechanism by which our ncRNAs function to
enhance gene expression is not known. We envision a mecha-
nism by which ncRNAs by virtue of sequence or structural
homology targets the neighboring protein-coding genes to bring
about increased expression. Our experimental evidence using
a heterologous promoter point to the mechanism of action for
activating ncRNAs operating in cis. However, genome-wide
analysis following depletion of ncRNA-a7 suggested changes
in gene expression that may not be related to the action of
ncRNA-a7 on its local environment and may be a result of wider
trans-mediated effects of ncRNA-a7. Such regulatory functions
of ncRNAs could be achieved through an RNA-mediated recruit-
ment of a transcriptional activator, displacement of a transcrip-
tional repressor, recruitment of a basal transcription factor or
a chromatin-remodeling factor. While we favor a transcriptional
based mechanism for ncRNA activation, effects on RNA stability
cannot be excluded. Taken together, the next few years will bring
about new prospects for the long ncRNAs as central players in
gene expression.
EXPERIMENTAL PROCEDURES
Extracting Long ncRNA Data
The HAVANA annotation has been downloaded using the DAS server provided
by the Sanger institute (version July,16th 2008). We removed all annotated
biotypes or functional elements belonging to specific categories such as pseu-
dogenes or protein-coding genes. We excluded all transcripts overlapping
with known protein coding loci annotated by HAVANA, RefSeq or UCSC. Tran-
scripts falling into a 1 kb window of any protein-coding gene were also
removed. Finally, we excluded all transcripts covered by known noncoding
RNAs such as miRNAs (miRbase version 11.0 April 2008).
To estimate the evolutionary constraints among mammalian sequences we
constructed the cumulative distribution of PhastCons scores for ancestral
repeats (ARs), RefSeq genes and long ncRNAs. The cumulative distributions
of these transcripts or repeats are plotted using a log-scale on the y axis.
Cell Culture and siRNA Transfections
Human primary keratinocytes from four different biological donors were grown
in Keratinocyte medium (KFSM, Invitrogen). Differentiation was induced by
2.5 ng/ml 12-O-tetradecanoylphorbol-13-acetate (TPA) during 48 hr.
HEK293, A549, HeLa, and MCF-7 cells were cultured in complete DMEM
media (GIBCO) containing 10% FBS, and 13 Anti/Anti (GIBCO). Jurkat cells
were cultured in complete RPMI media (GIBCO) containing 10% FBS and
13 Anti/Anti (GIBCO). Migration assays were performed as previously
described(Gumireddy et al., 2009).
For transfections of 293, HeLa, A549, and MCF-7 cells we used Lipofect-
amine 2000 (Invitrogen) according to the manufacturer’s recommendations
and an siRNA concentration of 50 nM. Jurkat cells were transfected using
HiPerFect (QIAGEN) according to the manufacturer’s recommendations and
an siRNA concentration of 100 nM.
RNA Purification, cDNA Synthesis, and Quantitative PCR
Cells were harvested and resuspended in TRIzol (Invitrogen) and RNA ex-
tracted according to the manufacturer’s protocol. cDNA synthesis was done
usingMultiScribe reverse transcriptase and random primers from Applied Bio-
systems. Quantitative PCR was done using SybrGreen reaction mix (Applied
Biosystems) and an HT7900 sequence detection system (Applied Biosys-
tems). For all quantitative PCR reactions Gapdh was measured for an internal
control and used to normalize the data.
Cloning of pGL3-TK Reporters and Luciferase Assay
pGL3-Basic was digested with BglII and HindIII and the TK promoter from
pRL-TK was inserted into these sites. Inserts were amplified from genomic
DNA and cloned into the BamHI and SalI sites 50 to the luciferase gene. Lucif-
erase assayswere performed in 96-well white plates usingDual-Glo (Promega)
according to the manufacturer’s protocol.
Microarrays
Custom-made microarrays (Agilent) were designed based on the library of
3019 long ncRNA sequences, with on average six probes targeting each tran-
script. Human whole genome mRNA arrays were from Agilent (G4112F). Total
RNA samples were converted to cDNA using oligo-dT primers. Labeling of the
cDNA and hybridization to the microarrays were performed according to Agi-
lent standard dye swap protocols. Data analysis was done using the AFM 4.0
software. All microarrays were done in four biological replicates.
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